EXPENSE REIMBURSEMENT AGREEMENT
Exhibit (h)(11)
EXPENSE REIMBURSEMENT AGREEMENT
EXPENSE REIMBURSEMENT AGREEMENT, by and between Ivy Investment Management Company (“IICO”), Ivy Funds Distributor, Inc. (“IFDI”) and Xxxxxxx & Xxxx Services Company (“WRSCO”) and Ivy Funds, on behalf of its series designated Ivy Asset Strategy New Opportunities Fund (the “Fund”).
WHEREAS, Ivy Funds, a Delaware statutory trust, is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-ended management investment company of the series type, and the Fund is a series of Ivy Funds; and
WHEREAS, Ivy Funds, IICO, IFDI and WRSCO have determined that it is appropriate and in the best interests of the Fund and its shareholders to maintain the expenses of Class A, Class E, Class I and Class Y of the Fund at a level below the level to which the expenses of Class A, Class E, Class I and Class Y may normally be subject;
NOW THEREFORE, the parties hereto agree as follows:
1. | Reimbursement of Expenses. |
1.1 | Applicable Reimbursement Level and Term of Reimbursement. For the period from April 1, 2010 through July 31, 2011, IICO, IFDI and/or WRSCO agrees to reimburse sufficient management fees, 12b-1fees and/or shareholder servicing fees to cap the expenses for Class A, Class E and Class Y at 1.50% and for Class I at 1.25% (the “Reimbursement Amount”). |
1.2 | Payment of Reimbursement Amount. To effect the expense reimbursement provided for in this Agreement, the Fund, on behalf of Class A, Class E and Class Y, may offset the appropriate Reimbursement Amount against the management fees, 12b-1 fees and/or shareholder servicing fees payable under the Investment Management Agreement, 12b-1 Plan and/or the Shareholder Servicing Agreement. Alternatively, the Reimbursement Amount shall be paid quarterly by IICO, IFDI and/or WRSCO within the first 10 days of each calendar quarter. |
2. | Termination and Effectiveness of Agreement. |
2.1 | Termination. This Agreement shall terminate with respect to the applicable Class of shares of the Fund upon termination of the Fund’s Investment Management Agreement, 12b-1 Plan and/or the Shareholder Servicing Agreement or on July 31, 2011, whichever comes first. |
3. | Miscellaneous. |
3.1 | Captions. The captions in this Agreement are included for convenience of reference only and in no other way define or delineate any of the provisions hereof. |
3.2 | Interpretation. Nothing contained herein shall be deemed to require Ivy Funds or the Fund to take any action contrary to the Ivy Funds’ Declaration of Trust or By-Laws, or any applicable statutory or regulatory requirement to which it is subject or by which it is bound, or to relieve or deprive the Board of Trustees of Ivy Funds of its responsibility for and control of the conduct of the affairs of Ivy Funds or the Fund. |
3.3 | Definitions. Any question of interpretation of any term or provision of this Agreement, including but not limited to the management fees, the 12b-1 Plan and/or shareholder servicing fees, the computations of net asset values, and the allocation of expenses, having a counterpart or otherwise derived from the terms and provisions of the Investment Management Agreement, 12b-1 Plan, the Shareholder Servicing Agreement or the 1940 Act, shall have the same meaning as and be resolved by reference to the 12b-1 Plan, the Shareholder Servicing Agreement or the 1940 Act. |
IN WITNESS WHEREOF, the parties have caused this Agreement to be signed by their respective officers thereunto duly authorized and their respective corporate seals to be hereunto affixed, as of April 1, 2010.
XXXXXXX & XXXX SERVICES COMPANY |
IVY FUNDS, on behalf of its series, IVY ASSET STRATEGY NEW OPPORTUNITIES FUND | |||||||
By: |
/s/ Xxxxxxx X. Xxxxxx |
By: | /s/ Xxxx X. Xxxxxxxxxx | |||||
Xxxxxxx X. Xxxxxx, President | Xxxx X. Xxxxxxxxxx, Vice President | |||||||
IVY FUNDS DISTRIBUTOR, INC. |
IVY INVESTMENT MANAGEMENT COMPANY | |||||||
By: |
/s/ Xxxxxx X. Xxxxx |
By: | /s/ Xxxxx X. Xxxxxxxx | |||||
Xxxxxx X. Xxxxx, President | Xxxxx X. Xxxxxxxx, President |